Key | % Net Assets |
---|---|
Boots 5.5% £ Bonds 26/5/2009 | 1.9% |
Linde Finance 8.125% £ Bonds 14/7/2066 | 1.5% |
GlaxoSmithKline | 1.4% |
VNU 5.625% £ MTN 20/5/2010 | 1.4% |
Other | 93.8% |
Name | % Net Assets |
---|---|
Boots 5.5% £ Bonds 26/5/2009 | 1.9% |
Linde Finance 8.125% £ Bonds 14/7/2066 | 1.5% |
GlaxoSmithKline | 1.4% |
VNU 5.625% £ MTN 20/5/2010 | 1.4% |
SLM 5.375% £ Bonds 15/12/2010 | 1.3% |
AstraZeneca | 1.3% |
Intergen 9.5% £ Bonds 30/6/2017 | 1.2% |
NTL Cable 9.75% £ Bonds 15/4/2014 | 1.2% |
BG | 1.1% |
British American Tobacco | 1.1% |
No asset data available.
Date | 21-Nov-2024 |
---|---|
NAV | 248.04p |
Currency | GBP |
Change | -0.16p |
% | -0.06% |
YTD change | 12.58p |
YTD % | 5.34% |
Fund Inception | 06/02/1999 |
---|---|
Fund Manager | Paul Causer / Paul Read / Neil Woodford |
TER | 0.94 (31-Dec-2013) |
Minimum Investment | |
---|---|
Initial | £500 |
Additional | n/a |
Savings | £20 |
Charges | |
---|---|
Initial | 5.00% |
Annual Mang't | 0.92% |
Exit | n/a |
Name | % |
---|---|
No risk data available. |
You are here: research